cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.14430500
title: Supplementary Material for: Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial

description: <b><i>Background:</i></b> Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor licensed for the treatment of type 2 diabetes mellitus (T2DM), has been reported to improve psoriasis. <b><i>Objective:</i></b> We compared the effects of sitagliptin treatment, a DPP-4 inhibitor, in combination with narrow-band ultraviolet-B (NB-UVB) phototherapy compared to NB-UVB alone on psoriasis severity, quality of life, cardiovascular disease risk factors and immune parameters in people with moderate psoriasis without T2DM. <b><i>Methods:</i></b> In this 39-week, single-centre, randomised controlled trial, people were allocated randomly to receive sitagliptin for 24 weeks with NB-UVB or NB-UVB alone. The primary endpoint was the change in Psoriasis Area and Severity Index (PASI) from baseline to 24 weeks. We estimated that 120 participants would be needed to have 80% power to find a significant difference between the groups. <b><i>Results:</i></b> A total of 118 patients were randomised. The median (IQR) baseline PASI was 8.8 (7.5–11.6). At 24 weeks, the mean difference from baseline in PASI (–1.0 [95% CI –2.0 to 0.0]) was significantly larger in the sitagliptin/NB-UVB arm than in the NB-UVB-alone arm (<i>p</i> = 0.044). There were significant differences in the change in Hospital Anxiety and Depression Scale (–2.5 [95% CI –4.0 to –1.0]; <i>p</i> = 0.002) and EuroQol 5-item questionnaire (0.1 [95% CI 0.0–0.1]; <i>p</i> = 0.036) values from baseline to 24 weeks between the sitagliptin/NB-UVB and the NB-UVB-alone arm. There were no treatment-related serious adverse events. <b><i>Conclusion:</i></b> Sitagliptin therapy combined with NB-UVB phototherapy significantly improved psoriasis severity, albeit modestly, compared to NB-UVB phototherapy alone in patients with moderate psoriasis without T2DM.
DOI: 10.6084/m9.figshare.14430839
title: Supplementary Material for: Diabetes, Age, and Duration of Supplementation Subgroup Analysis for the Effect of Coenzyme Q10 on Oxidative Stress: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Coenzyme Q10 (CoQ10) has been known as ubiquinone or ubidecarenone, which is a kind of lipid-soluble and vitamin-like antioxidant. It has a potent antioxidant effect against oxidation status via various mechanisms, including its ability to regenerate other antioxidants, such as vitamin E and vitamin C, and to increase antioxidant enzymes. Moreover, CoQ10 can quench free radicals and prevent lipid peroxidation. The aim of this systematic review and meta-analysis was to evaluate the effect of CoQ10 on oxidative stress variables. <b><i>Methods:</i></b> A comprehensive electronic database search in Scopus, Web of Science, Embase, Cochrane Library, and Medline was performed to identify eligible randomized clinical trials. A meta-analysis of included studies was performed on selected variables using a random-effects model. Quality assessment was conducted by means of the Cochrane risk of bias assessment tool. <b><i>Results:</i></b> To evaluate the effect of CoQ10 supplementation, 17 trials and 972 participants were included for the meta-analysis. The pooled analysis of primary studies showed that CoQ10 increased serum total antioxidant capacity (standardized mean difference [SMD] 0.62 mmol/L, 95% CI 0.18–1.05, <i>I</i><sup>2</sup> = 76.1%, <i>p</i> ˂ 0.001) and superoxide dismutase (SMD 0.40 U/mg, 95% CI 0.12–0.67, <i>I</i><sup>2</sup> = 9.6%, <i>p</i> ˂ 0.345) levels and decreased malondialdehyde (SMD –1.02 mmol/L, 95% CI –1.60 to –0.44, <i>I</i><sup>2</sup> = 88.2%, <i>p</i> ˂ 0.001) level significantly compared to the placebo group. Although the effect of CoQ10 on nitric oxide (SMD 1.01 µmol/L, 95% CI –1.53 to 3.54, <i>p</i> ˂ 0.001, <i>I</i><sup>2</sup> = 97.8%) and glutathione peroxidase (SMD –0.01 mmol/L, 95% CI –0.86 to 0.84, <i>p</i> ˂ 0.001, <i>I</i><sup>2</sup> = 88.6%) was not significant, CoQ10 can be mentioned as an improvement in antioxidant defense status against reactive oxygen species. <b><i>Conclusion:</i></b> These supplements have positive effects on antioxidant defense against oxidizing agents and elevate antioxidant enzyme levels in the body. However, due to limited research the results should be taken with caution.
DOI: 10.6084/m9.figshare.14430839.v1
title: Supplementary Material for: Diabetes, Age, and Duration of Supplementation Subgroup Analysis for the Effect of Coenzyme Q10 on Oxidative Stress: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Coenzyme Q10 (CoQ10) has been known as ubiquinone or ubidecarenone, which is a kind of lipid-soluble and vitamin-like antioxidant. It has a potent antioxidant effect against oxidation status via various mechanisms, including its ability to regenerate other antioxidants, such as vitamin E and vitamin C, and to increase antioxidant enzymes. Moreover, CoQ10 can quench free radicals and prevent lipid peroxidation. The aim of this systematic review and meta-analysis was to evaluate the effect of CoQ10 on oxidative stress variables. <b><i>Methods:</i></b> A comprehensive electronic database search in Scopus, Web of Science, Embase, Cochrane Library, and Medline was performed to identify eligible randomized clinical trials. A meta-analysis of included studies was performed on selected variables using a random-effects model. Quality assessment was conducted by means of the Cochrane risk of bias assessment tool. <b><i>Results:</i></b> To evaluate the effect of CoQ10 supplementation, 17 trials and 972 participants were included for the meta-analysis. The pooled analysis of primary studies showed that CoQ10 increased serum total antioxidant capacity (standardized mean difference [SMD] 0.62 mmol/L, 95% CI 0.18–1.05, <i>I</i><sup>2</sup> = 76.1%, <i>p</i> ˂ 0.001) and superoxide dismutase (SMD 0.40 U/mg, 95% CI 0.12–0.67, <i>I</i><sup>2</sup> = 9.6%, <i>p</i> ˂ 0.345) levels and decreased malondialdehyde (SMD –1.02 mmol/L, 95% CI –1.60 to –0.44, <i>I</i><sup>2</sup> = 88.2%, <i>p</i> ˂ 0.001) level significantly compared to the placebo group. Although the effect of CoQ10 on nitric oxide (SMD 1.01 µmol/L, 95% CI –1.53 to 3.54, <i>p</i> ˂ 0.001, <i>I</i><sup>2</sup> = 97.8%) and glutathione peroxidase (SMD –0.01 mmol/L, 95% CI –0.86 to 0.84, <i>p</i> ˂ 0.001, <i>I</i><sup>2</sup> = 88.6%) was not significant, CoQ10 can be mentioned as an improvement in antioxidant defense status against reactive oxygen species. <b><i>Conclusion:</i></b> These supplements have positive effects on antioxidant defense against oxidizing agents and elevate antioxidant enzyme levels in the body. However, due to limited research the results should be taken with caution.
DOI: 10.6084/m9.figshare.14430842
title: Supplementary Material for: Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy

description: <b><i>Background:</i></b> IgA nephropathy (IgAN) is characterized by the mesangial deposition of pathogenic IgA. We previously detected the deposition of pathogenic secretory IgA (SIgA) in the mesangium of about one-third of IgAN patients. Tubulointerstitial injury has an important role in the development of IgAN. However, the relationship between SIgA and tubulointerstitial damage is currently unclear. In this work, the role of the mesangial-tubular crosstalk was explored in the tubulointerstitial damage in SIgA-induced IgAN. <b><i>Methods:</i></b> SIgA deposition in renal tissues of IgAN patients was detected by immunofluorescence. Flow cytometry was used to assess the binding of SIgA to human renal mesangial cells (HRMC) and human proximal tubule epithelial (HK-2) cells. HK-2 was co-cultured with HRMC added with SIgA isolated from patients or normal volunteers. Protein synthesis and gene expressions of TNF-α, TGF-β1, and MCP-1 were determined by ELISA and PCR, respectively. The expressions of the above cytokines in renal tissues of patients and normal controls were detected by immunohistochemistry. <b><i>Results:</i></b> Twenty-nine of 96 patients had SIgA deposition in the mesangium, but SIgA was rarely detected in the tubulointerstitium. The binding rate of SIgA to HK-2 (2.79%) was significantly lower than that of HRMC (81.6%) (<i>p</i> &lt; 0.001). The expressions of TNF-α, TGF-β1, and MCP-1 in HRMC were significantly higher than in SIgA-stimulated HK-2 (<i>p</i> &lt; 0.05), and their expressions were significantly higher in the SIgA-stimulated co-culture group compared with SIgA-stimulated HRMC (<i>p</i> &lt; 0.05). The expressions of the above cytokines were mainly detected in tubulointerstitium of IgAN patients with positive and negative SIgA deposition, without significant difference between the 2 groups, but to a significantly higher level than that in normal controls, and their expressions positively correlated with tubulointerstitial injury. <b><i>Conclusion:</i></b> Inflammatory factors released from the mesangium after SIgA deposition might mediate tubulointerstitial damage via mesangial-tubular crosstalk in IgAN.
DOI: 10.6084/m9.figshare.14430842.v1
title: Supplementary Material for: Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy

description: <b><i>Background:</i></b> IgA nephropathy (IgAN) is characterized by the mesangial deposition of pathogenic IgA. We previously detected the deposition of pathogenic secretory IgA (SIgA) in the mesangium of about one-third of IgAN patients. Tubulointerstitial injury has an important role in the development of IgAN. However, the relationship between SIgA and tubulointerstitial damage is currently unclear. In this work, the role of the mesangial-tubular crosstalk was explored in the tubulointerstitial damage in SIgA-induced IgAN. <b><i>Methods:</i></b> SIgA deposition in renal tissues of IgAN patients was detected by immunofluorescence. Flow cytometry was used to assess the binding of SIgA to human renal mesangial cells (HRMC) and human proximal tubule epithelial (HK-2) cells. HK-2 was co-cultured with HRMC added with SIgA isolated from patients or normal volunteers. Protein synthesis and gene expressions of TNF-α, TGF-β1, and MCP-1 were determined by ELISA and PCR, respectively. The expressions of the above cytokines in renal tissues of patients and normal controls were detected by immunohistochemistry. <b><i>Results:</i></b> Twenty-nine of 96 patients had SIgA deposition in the mesangium, but SIgA was rarely detected in the tubulointerstitium. The binding rate of SIgA to HK-2 (2.79%) was significantly lower than that of HRMC (81.6%) (<i>p</i> &lt; 0.001). The expressions of TNF-α, TGF-β1, and MCP-1 in HRMC were significantly higher than in SIgA-stimulated HK-2 (<i>p</i> &lt; 0.05), and their expressions were significantly higher in the SIgA-stimulated co-culture group compared with SIgA-stimulated HRMC (<i>p</i> &lt; 0.05). The expressions of the above cytokines were mainly detected in tubulointerstitium of IgAN patients with positive and negative SIgA deposition, without significant difference between the 2 groups, but to a significantly higher level than that in normal controls, and their expressions positively correlated with tubulointerstitial injury. <b><i>Conclusion:</i></b> Inflammatory factors released from the mesangium after SIgA deposition might mediate tubulointerstitial damage via mesangial-tubular crosstalk in IgAN.
DOI: 10.11583/dtu.14237138
title: Turbulence measurements from the two Alsvik masts

description: 1 Hz data at eight levels on two 54 m towers during four years. 20 Hz data at three levels on one 54 m tower during one year.<br>Detailed site documentation is available here.<br><br><b>Data files:</b>1) alsvik_all.nc2) alsvik_concurrent.nc<br><br>Raw time series each with a duration of 3600 sec and sampled with 1 Hz:3) alsvik_1991.zip4) alsvik_1992.zip<br>5) alsvik_1993.zip<br>6) alsvik_1994.zip<br>
DOI: 10.11583/dtu.14237138.v1
title: Turbulence measurements from the two Alsvik masts

description: 1 Hz data at eight levels on two 54 m towers during four years. 20 Hz data at three levels on one 54 m tower during one year.<br>Detailed site documentation is available here.<br><br><b>Data files:</b>1) alsvik_all.nc2) alsvik_concurrent.nc<br><br>Raw time series each with a duration of 3600 sec and sampled with 1 Hz:3) alsvik_1991.zip4) alsvik_1992.zip<br>5) alsvik_1993.zip<br>6) alsvik_1994.zip<br>
DOI: 10.5281/zenodo.4695823
title: Pycirk exiobase data

description: A version of EXIOBASE multi-regional SUTs V3.3 for 2011 and that has been: Expanded in labels for all categories (including synonyms, country regions and names in the multiindexes to facilitate slicing). Expanded by including characterization tables (originally developed under DESIRE FP7) The datasets are pickled and are meant to be used with pycirk a modelling software to simulate EEIO structural change due to technological and policy interventions. https://cmlplatform.github.io/pycirk/
DOI: 10.15468/cmp6ue
title: First record of stygobiotic gastropod genus Travunijana Grego & Gloeer, 2019 (Mollusca, Hydrobiidae) from Montenegro

description: This dataset contains the digitized treatments in Plazi based on the original journal article Grego 1, Jozef, Pesic 2, Vladimir (2021): First record of stygobiotic gastropod genus Travunijana Grego & Gloeer, 2019 (Mollusca, Hydrobiidae) from Montenegro. Subterranean Biology 38: 65-76, DOI: http://dx.doi.org/10.3897/subtbiol.38.64762, URL: http://dx.doi.org/10.3897/subtbiol.38.64762
DOI: 10.15468/xqtp5z
title: Geosesarma sodalis, a new species of vampire crab (Crustacea, Brachyura, Sesarmidae) from a limestone cave in central Sarawak, Malaysia

description: This dataset contains the digitized treatments in Plazi based on the original journal article Ng, Peter K. L. (2021): Geosesarma sodalis, a new species of vampire crab (Crustacea, Brachyura, Sesarmidae) from a limestone cave in central Sarawak, Malaysia. ZooKeys 1031: 133-141, DOI: http://dx.doi.org/10.3897/zookeys.1031.63134, URL: http://dx.doi.org/10.3897/zookeys.1031.63134
DOI: 10.15468/v5rzt9
title: Description of three new species of Automeris Huebner, 1819 from Colombia and Brazil (Lepidoptera, Saturniidae, Hemileucinae)

description: This dataset contains the digitized treatments in Plazi based on the original journal article Decaens, Thibaud, Beneluz, Frederic, Ballesteros-Mejia, Liliana, Bonilla, Diego, Rougerie, Rodolphe (2021): Description of three new species of Automeris Huebner, 1819 from Colombia and Brazil (Lepidoptera, Saturniidae, Hemileucinae). ZooKeys 1031: 183-204, DOI: http://dx.doi.org/10.3897/zookeys.1031.56035, URL: http://dx.doi.org/10.3897/zookeys.1031.56035
DOI: 10.15468/pdq83y
title: Belarima violacea (Lucas, 1847) (Coleoptera, Chrysomelidae), a new genus and species for the European fauna

description: This dataset contains the digitized treatments in Plazi based on the original journal article Violi, Michele, D'Alessandro, Paola, Biondi, Maurizio (2021): Belarima violacea (Lucas, 1847) (Coleoptera, Chrysomelidae), a new genus and species for the European fauna. ZooKeys 1031: 125-131, DOI: http://dx.doi.org/10.3897/zookeys.1031.61846, URL: http://dx.doi.org/10.3897/zookeys.1031.61846
DOI: 10.15468/nuchgy
title: The resin bee subgenus Ranthidiellum in Thailand (Megachilidae, Anthidiini): nesting biology, cleptoparasitism by Stelis, and new species

description: This dataset contains the digitized treatments in Plazi based on the original journal article Nalinrachatakan, Pakorn, Traiyasut, Prapun, Khongnak, Anupong, Muangkam, Manop, Ascher, John S., Warrit, Natapot (2021): The resin bee subgenus Ranthidiellum in Thailand (Megachilidae, Anthidiini): nesting biology, cleptoparasitism by Stelis, and new species. ZooKeys 1031: 161-182, DOI: http://dx.doi.org/10.3897/zookeys.1031.57836, URL: http://dx.doi.org/10.3897/zookeys.1031.57836
DOI: 10.15468/j3gzfr
title: The first two blind troglobitic spiders of the genus Ochyrocera from caves in Floresta Nacional de Carajas, state of Para, Brazil (Araneae, Ochyroceratidae)

description: This dataset contains the digitized treatments in Plazi based on the original journal article Brescovit, Antonio D., Zampaulo, Robson de A., Cizauskas, Igor (2021): The first two blind troglobitic spiders of the genus Ochyrocera from caves in Floresta Nacional de Carajas, state of Para, Brazil (Araneae, Ochyroceratidae). ZooKeys 1031: 143-159, DOI: http://dx.doi.org/10.3897/zookeys.1031.62181, URL: http://dx.doi.org/10.3897/zookeys.1031.62181
DOI: 10.6084/m9.figshare.14430998
title: Dataset

description: Inputs and results underpinning the findings of the manuscript "Unsaturated zone model complexity for the assimilation of evapotranspiration rates in groundwater modelling"
DOI: 10.6084/m9.figshare.14430725
title: Supplementary Material for: Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice

description: Diseases can affect organs such as the heart, lungs, brain, muscles, or vocal folds, which can then alter an individual’s voice. Therefore, voice analysis using artificial intelligence opens new opportunities for healthcare. From using vocal biomarkers for diagnosis, risk prediction, and remote monitoring of various clinical outcomes and symptoms, we offer in this review an overview of the various applications of voice for health-related purposes. We discuss the potential of this rapidly evolving environment from a research, patient, and clinical perspective. We also discuss the key challenges to overcome in the near future for a substantial and efficient use of voice in healthcare.
DOI: 10.6084/m9.figshare.14430725.v1
title: Supplementary Material for: Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice

description: Diseases can affect organs such as the heart, lungs, brain, muscles, or vocal folds, which can then alter an individual’s voice. Therefore, voice analysis using artificial intelligence opens new opportunities for healthcare. From using vocal biomarkers for diagnosis, risk prediction, and remote monitoring of various clinical outcomes and symptoms, we offer in this review an overview of the various applications of voice for health-related purposes. We discuss the potential of this rapidly evolving environment from a research, patient, and clinical perspective. We also discuss the key challenges to overcome in the near future for a substantial and efficient use of voice in healthcare.
DOI: 10.6084/m9.figshare.14431049
title: Investigation of contamination pathway and human health risk assessment from metals due to the consumption of cow’s milk: a mass balance approach

description: This is supporting information for the publication.
DOI: 10.6084/m9.figshare.14431049.v1
title: Investigation of contamination pathway and human health risk assessment from metals due to the consumption of cow’s milk: a mass balance approach

description: This is supporting information for the publication.
DOI: 10.6084/m9.figshare.14431112
title: Supplementary Material for: Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study

description: Medicine
DOI: 10.6084/m9.figshare.14431112.v1
title: Supplementary Material for: Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study

description: Medicine
DOI: 10.6084/m9.figshare.14431079
title: Copy number alterations of 317 HNSCCs

description: Copy number alterations of 317 HNSCCs
DOI: 10.6084/m9.figshare.14431067
title: SNVs and INDELs of 317 HNSCCs

description: SNVs and INDELs of 317 HNSCCs
DOI: 10.6084/m9.figshare.14430992
title: Clinical Information of 317 HNSCCs

description: Clinical Information of 317 HNSCCs
DOI: 10.6084/m9.figshare.14430992.v1
title: Clinical Information of 317 HNSCCs

description: Clinical Information of 317 HNSCCs
DOI: 10.34810/data40/1
title: AMINOCRET_IRTA_MTT_210311_TS1.csv

description: :unav
DOI: 10.34810/data40/2
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS1.txt

description: :unav
DOI: 10.34810/data40/3
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS1.txt

description: :unav
DOI: 10.26180/14431199.v1
title: Fumarate reductase subunit A

description: Fumarate reductase subunit A
DOI: 10.6084/m9.figshare.14131898
title: MEDICAL EDUCATION COVID-19

description: COVID-19 MEDICAL EDUCATION<br>
DOI: 10.6084/m9.figshare.14131898.v2
title: MEDICAL EDUCATION COVID-19

description: COVID-19 MEDICAL EDUCATION<br>
DOI: 10.6084/m9.figshare.14131898.v1
title: MEDICAL EDUCATION COVID-19

description: COVID-19 MEDICAL EDUCATION<br>
DOI: 10.34810/data43/1
title: AMINOCRET_IRTA_MTT_20210311_TS4.csv

description: :unav
DOI: 10.34810/data43/2
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS4.txt

description: :unav
DOI: 10.34810/data43/3
title: Readme file for AMINOCRET_IRTA_MTT_20210311_TS4.docx

description: :unav
DOI: 10.34810/data41/1
title: AMINOCRET_IRTA_MTT_210311_TS2.csv

description: :unav
DOI: 10.34810/data41/2
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS2.txt

description: :unav
DOI: 10.6084/m9.figshare.14431205.v1
title: Ciranna_data_analysis_EurJNeurosci2021.pdf

description: Description of methods for acquisition and analysis of data shown in the article: <b>Costa L., Tempio A., Lacivita E., Leopoldo M. and Ciranna L.</b> (2021). Serotonin 5-HT7 receptors require Cyclin-Dependent Kinase 5 to rescue hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome. <i>Eur. J. Neurosci.</i> (in press).<br>
DOI: 10.34810/data41/3
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS2.txt

description: :unav
DOI: 10.6084/m9.figshare.14431205
title: Ciranna_data_analysis_EurJNeurosci2021.pdf

description: Description of methods for acquisition and analysis of data shown in the article: <b>Costa L., Tempio A., Lacivita E., Leopoldo M. and Ciranna L.</b> (2021). Serotonin 5-HT7 receptors require Cyclin-Dependent Kinase 5 to rescue hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome. <i>Eur. J. Neurosci.</i> (in press).<br>
DOI: 10.34740/kaggle/dsv/2108063
title: Dutch News Articles
DOI: 10.34810/data42/1
title: AMINOCRET_IRTA_MTT_20210311_TS3.csv

description: :unav
DOI: 10.34810/data42/2
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS3.txt

description: :unav
DOI: 10.34810/data42/3
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS3.txt

description: :unav
DOI: 10.34810/data42/4
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS3.txt

description: :unav
DOI: 10.34810/data42/5
title: Readme_AMINOCRET_IRTA_MTT_20210311_TS3.txt

description: :unav
DOI: 10.5281/zenodo.4529610
title: Population in the Arctic Circumpolar Permafrost Region at settlement level

description: Database of populaiton in the Arctic Circumpolar Permafrost Region at settlement level in 2017. For information about sources and feature attributes, see included metadata sheet. Contact: Justine Ramage, justine.ramage@nordregio.org
description: {"references": ["Obu, J., Westermann, S., Bartsch, A., Berdnikov, N., Christiansen, H. H., Dashtseren, A., Delaloye, R., Elberling, B., Etzelm\u00fcller, B., Kholodov, A., Khomutov, A., K\u00e4\u00e4b, A., Leibman, M. O., Lewkowicz, A. G., Panda, S. K., Romanovsky, V., Way, R. G., Westergaard-Nielsen, A., Wu, T., \u2026 Zou, D. (2019). Northern Hemisphere permafrost map based on TTOP modelling for 2000\u20132016 at 1 km2 scale. Earth-Science Reviews, 193, 299\u2013316. https://doi.org/10.1016/j.earscirev.2019.04.023", "Hjort, J., Karjalainen, O., Aalto, J., Westermann, S., Romanovsky, V. E., Nelson, F. E., Etzelm\u00fcller, B., & Luoto, M. (2018). Degrading permafrost puts Arctic infrastructure at risk by mid-century. Nature Communications, 9(1), 5147. https://doi.org/10.1038/s41467-018-07557-4"]}